Pathnova

PATHNOVA is an emerging company in Singapore that spun off from Temasek Life Sciences Laboratory in 2017. PATHNOVA is committed to enabling scalable detection of nasopharyngeal carcinoma (NPC) and autoimmune diseases by developing an AI framework trained by Emeritus Professor Chan Soh Ha. The immunofluorescence assay (IFA) from the 1970s is used as the gold standard test for detecting NPC.